Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 3, 2023
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
Jonathan Yong Maintained (AMN) at Buy with Decreased Target to $128 on, Apr 3rd, 2023
Jonathan Yong of Credit Suisse, Maintained "AMN Healthcare Services, Inc." (AMN) at Buy with Decreased Target from $147 to $128 on, Apr 3rd, 2023.
Jonathan has made no other calls on AMN in the last 4 months.
There are 3 other peers that have a rating on AMN. Out of the 3 peers that are also analyzing AMN, 1 agrees with Jonathan's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Mark Marcon of "Baird" Maintained at Hold with Decreased Target to $111 on, Friday, February 17th, 2023
These are the ratings of the 2 analyists that currently disagree with Jonathan
- Jeffrey Silber of "BMO Capital" Maintained at Buy with Decreased Target to $109 on, Tuesday, February 21st, 2023
- Bill Sutherland of "Benchmark" Reiterated at Strong Buy and Held Target at $148 on, Monday, February 13th, 2023
